Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration
- PMID: 18653558
- DOI: 10.1242/dev.023788
Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration
Abstract
The fetal skeleton arises from neural crest and from mesoderm. Here, we provide evidence that each lineage contributes a unique stem cell population to the regeneration of injured adult bones. Using Wnt1Cre::Z/EG mice we found that the neural crest-derived mandible heals with neural crest-derived skeletal stem cells, whereas the mesoderm-derived tibia heals with mesoderm-derived stem cells. We tested whether skeletal stem cells from each lineage were functionally interchangeable by grafting mesoderm-derived cells into mandibular defects, and vice versa. All of the grafting scenarios, except one, healed through the direct differentiation of skeletal stem cells into osteoblasts; when mesoderm-derived cells were transplanted into tibial defects they differentiated into osteoblasts but when transplanted into mandibular defects they differentiated into chondrocytes. A mismatch between the Hox gene expression status of the host and donor cells might be responsible for this aberration in bone repair. We found that initially, mandibular skeletal progenitor cells are Hox-negative but that they adopt a Hoxa11-positive profile when transplanted into a tibial defect. Conversely, tibial skeletal progenitor cells are Hox-positive and maintain this Hox status even when transplanted into a Hox-negative mandibular defect. Skeletal progenitor cells from the two lineages also show differences in osteogenic potential and proliferation, which translate into more robust in vivo bone regeneration by neural crest-derived cells. Thus, embryonic origin and Hox gene expression status distinguish neural crest-derived from mesoderm-derived skeletal progenitor cells, and both characteristics influence the process of adult bone regeneration.
Similar articles
-
Neural crest and mesoderm lineage-dependent gene expression in orofacial development.Differentiation. 2007 Jun;75(5):463-77. doi: 10.1111/j.1432-0436.2006.00145.x. Epub 2007 Feb 5. Differentiation. 2007. PMID: 17286603
-
The effect of overexpression of Dlx2 on the migration, proliferation and osteogenic differentiation of cranial neural crest stem cells.Biomaterials. 2013 Mar;34(8):1898-910. doi: 10.1016/j.biomaterials.2012.11.051. Epub 2012 Dec 14. Biomaterials. 2013. PMID: 23246068
-
Spatial relations between avian craniofacial neural crest and paraxial mesoderm cells.Dev Dyn. 2006 May;235(5):1310-25. doi: 10.1002/dvdy.20663. Dev Dyn. 2006. PMID: 16395689
-
Circulating endothelial/skeletal progenitor cells for bone regeneration and healing.Bone. 2008 Sep;43(3):434-9. doi: 10.1016/j.bone.2008.05.001. Epub 2008 May 10. Bone. 2008. PMID: 18547890 Review.
-
Adult reserve stem cells and their potential for tissue engineering.Cell Biochem Biophys. 2004;40(1):1-80. doi: 10.1385/CBB:40:1:1. Cell Biochem Biophys. 2004. PMID: 14983110 Review.
Cited by
-
Periosteum Containing Implicit Stem Cells: A Progressive Source of Inspiration for Bone Tissue Regeneration.Int J Mol Sci. 2024 Feb 10;25(4):2162. doi: 10.3390/ijms25042162. Int J Mol Sci. 2024. PMID: 38396834 Free PMC article. Review.
-
2-N, 6-O sulfated chitosan evokes periosteal stem cells for bone regeneration.Bioact Mater. 2024 Jan 3;34:282-297. doi: 10.1016/j.bioactmat.2023.12.016. eCollection 2024 Apr. Bioact Mater. 2024. PMID: 38261845 Free PMC article.
-
Biomaterial scaffolds in maxillofacial bone tissue engineering: A review of recent advances.Bioact Mater. 2023 Nov 10;33:129-156. doi: 10.1016/j.bioactmat.2023.10.031. eCollection 2024 Mar. Bioact Mater. 2023. PMID: 38024227 Free PMC article. Review.
-
Site-specific periosteal cells with distinct osteogenic and angiogenic characteristics.Clin Oral Investig. 2023 Dec;27(12):7437-7450. doi: 10.1007/s00784-023-05333-3. Epub 2023 Oct 17. Clin Oral Investig. 2023. PMID: 37848582
-
Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments.Bone Rep. 2023 Jan 20;18:101656. doi: 10.1016/j.bonr.2023.101656. eCollection 2023 Jun. Bone Rep. 2023. PMID: 37425195 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
